Friday, March 29, 2024
HomeTagsCellenkos

Cellenkos

Cellenkos Receives FDA Clearance of Investigational New Drug (IND) Application for CK0803 for the Treatment of Amyotrophic Lateral Sclerosis

Cellenkos, Inc., a clinical stage biotech company that focuses on developing transformative cellular therapeutics for treatment of inflammatory disorders and autoimmune diseases, today announced...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics